Chronos Archive seal
The Human Record

Florence Griffith Joyner

Case HR-ML033-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
December 21, 1959 – September 21, 1998
Synthetic DOB
1959-12-21
Index visit
1996-04-22 at age 36
Synthetic MRN
HR-ML033-SYN-TD

Teaching objective: Evaluate an adult after a generalized seizure as the AAN/AES first unprovoked seizure guideline directs: history, examination and laboratory screen, EEG, and MRI of the brain with susceptibility-weighted imaging, which here shows a cavernous malformation; diagnose epilepsy after a single unprovoked seizure when an epileptogenic lesion makes recurrence likely (ILAE 1984 practical definition); choose an antiseizure medication for a woman who could become pregnant (levetiracetam or lamotrigine, with folic acid, contraception counseling and the reasons to avoid valproate, under the AAN/AES/SMFM 1994 guideline); refer for neurosurgical evaluation of an epileptogenic cavernous malformation and consider lesionectomy (Angioma Alliance 1987); tell her about SUDEP and how to lower the risk, as the AAN/AES 1987 guideline requires; give seizure safety advice for driving under California law, water and sleep, with nocturnal seizure detection; and plan a safe return to elite-level training.

Historical timeline

DateEventClaims
December 21, 1959Born in Los Angeles; grows up in Watts.CLM-0001
1983Graduates from UCLA.CLM-0002
1984Olympic silver medal in the 200 meters, Los Angeles.CLM-0002
1988World records at 100 and 200 meters; three Olympic gold medals and a silver in Seoul.CLM-0003
1989Retires from competition.CLM-0003
1990 to 1994Treated for seizures in 1990, 1993 and 1994, as later reported from the coroner's records.CLM-0006
1993Co-chair of the President's Council on Physical Fitness and Sports.CLM-0004
1995Inducted into the U.S. Track and Field Hall of Fame.CLM-0004
April 1996Seizure on a flight to St. Louis; discharged from hospital the next day.CLM-0005
September 21, 1998Dies in her sleep at home in Mission Viejo, California, at 38; the coroner reports positional asphyxia during an epileptic seizure caused by a cavernous angioma.CLM-0007

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Florence Griffith was born in Los Angeles on December 21, 1959, the seventh of eleven children, and grew up from the age of four in a public housing project in the Watts neighborhood of Los Angeles. Reference works give her given names in both orders, Delorez Florence and Florence Delorez. confirmed Florence Griffith Joyner (athlete profile) supports
Griffith Joyner, Florence (biographical entries) supports
HISTMED Master Roster v3 context
D She ran for California State University, Northridge, and then for UCLA, graduating in 1983, and won the silver medal in the 200 meters at the 1984 Olympic Games in Los Angeles, competing as Florence Griffith.
Anchors the modern social history of an elite sprinter.
confirmed Griffith Joyner, Florence (biographical entries) supports
Florence Griffith Joyner (athlete profile) supports
D In 1988 she set a world record of 10.49 seconds for 100 meters at the U.S. Olympic Trials and, at the Seoul Olympic Games, won gold medals in the 100 meters, the 200 meters (in a world record of 21.34 seconds) and the 4 x 100 meters relay, and a silver medal in the 4 x 400 meters relay. She retired from competition in 1989.
Her athletic career anchors the modern goal of returning to training.
confirmed Florence Griffith Joyner (athlete profile) supports
Griffith Joyner, Florence (biographical entries) supports
No direct drug link to FloJo death supports
D In 1993 she was appointed co-chair of the President's Council on Physical Fitness and Sports, and in 1995 she was inducted into the U.S. Track and Field Hall of Fame. She also worked as a designer of clothing and athletic wear.
Her work in fitness and design anchors the modern social history.
confirmed Griffith Joyner, Florence (biographical entries) supports
Joyner autopsy reveals seizure (The Associated Press) context
D In April 1996 she had a seizure on an airplane on the way to St. Louis. She was taken to hospital and discharged the next day, and her family asked that no other details be released.
Reported during her life: the first publicly known seizure and the anchor for the modern episode, which begins about two and a half weeks later.
confirmed Flo Jo reportedly doing fine after having seizure on plane (The Associated Press) supports
Griffith Joyner, Florence (biographical entries) supports
D Coroner's investigation records, reported after her death, state that she had a generalized (grand mal) seizure in 1990 and had been treated for seizures in 1990, 1993 and 1994.
Earlier seizure history known only from records published after her death; it is recorded as history and is not expanded in the modern episode.
probable Rebelo Anderson K. The uneasy death of Florence Griffith Joyner supports
D She died in her sleep at her home in Mission Viejo, California, on September 21, 1998, at 38. The Orange County Sheriff-Coroner reported that she died of positional asphyxia during an epileptic seizure, and that the seizure was caused by a congenital cavernous angioma (cavernous malformation) of the left orbital frontal cerebrum.
The documented disease to which the synthetic diagnosis is linked. History only, stated without detail.
confirmed No direct drug link to FloJo death supports
Joyner autopsy reveals seizure (The Associated Press) supports
Autopsy proves Flo-Jo suffered an epileptic seizure supports
Rebelo Anderson K. The uneasy death of Florence Griffith Joyner supports
Florence Griffith Joyner (athlete profile) supports
Seizure, suffocation caused Flojo's death supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Generalized tonic-clonic seizure on a flight two and a half weeks ago, in a 36-year-old woman who was observed overnight in hospital elsewhere and has had treatment for seizures in the past, records requested; no antiseizure medication now; normal examination today. Evaluated as a new seizure: EEG and MRI of the brain with susceptibility-weighted imaging ordered, neurology (epilepsy) review booked, and no driving resolved confirmed active CLM-0005, CLM-0006
S Focal epilepsy with structural cause: focal to bilateral tonic-clonic seizure from a left orbitofrontal cavernous malformation, with left frontal epileptiform discharges on EEG; epilepsy under the ILAE 1984 practical definition (an unprovoked seizure with a recurrence risk above 60% from an epileptogenic lesion, and earlier seizures by history); synthetic modern detail linked to her publicly reported seizures and the coroner's finding active confirmed both_with_link CLM-0005, CLM-0006, CLM-0007
S Solitary cerebral cavernous malformation, 1.4 cm, left orbitofrontal cortex, with a hemosiderin rim and an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging (sporadic pattern); no acute hemorrhage resolved confirmed active CLM-0007

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1996-04-22 Hemoglobin [Mass/volume] in Blood 13.4 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1996-04-22 Leukocytes [#/volume] in Blood by Automated count 6.1 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1996-04-22 Platelets [#/volume] in Blood by Automated count 238 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1996-04-22 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1996-04-22 Potassium [Moles/volume] in Serum or Plasma 4.1 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1996-04-22 Creatinine [Mass/volume] in Serum or Plasma 0.92 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1996-04-22 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M 83 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1996-04-22 Glucose [Mass/volume] in Serum or Plasma 86 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1996-04-22 Calcium [Mass/volume] in Serum or Plasma 9.6 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1996-04-22 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 17 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1996-04-22 Magnesium [Mass/volume] in Serum or Plasma 2 mg/dL
Reference 1.7-2.2 mg/dL
http://loinc.org · 19123-9
S 1996-04-22 Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 168 U/L
Reference 26-192 U/L
http://loinc.org · 2157-6
S 1996-04-22 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1996-04-22 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 6 http://loinc.org · 70274-6
S 1996-05-05 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 1996-05-27 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1996-07-21 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 1996-10-20 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 http://loinc.org · 44261-6
S 1996-08-25 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7

Synthetic vital signs

DateMeasureResultLOINCGrade
1996-04-22Body height170 cm8302-2S
1996-04-22Body weight61 kg29463-7S
1996-04-22Body mass index (BMI) [Ratio]21.1 kg/m239156-5S
1996-04-22Systolic blood pressure112 mm[Hg]8480-6S
1996-04-22Diastolic blood pressure70 mm[Hg]8462-4S
1996-04-22Heart rate56 /min8867-4S
1996-04-22Respiratory rate14 /min9279-1S
1996-04-22Body temperature36.7 Cel8310-5S
1996-04-22Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1996-05-05Body height170 cm8302-2S
1996-05-05Body weight61.2 kg29463-7S
1996-05-05Body mass index (BMI) [Ratio]21.2 kg/m239156-5S
1996-05-05Systolic blood pressure110 mm[Hg]8480-6S
1996-05-05Diastolic blood pressure68 mm[Hg]8462-4S
1996-05-05Heart rate58 /min8867-4S
1996-05-05Respiratory rate14 /min9279-1S
1996-05-05Body temperature36.6 Cel8310-5S
1996-05-05Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1996-05-27Body height170 cm8302-2S
1996-05-27Body weight60.8 kg29463-7S
1996-05-27Body mass index (BMI) [Ratio]21 kg/m239156-5S
1996-05-27Systolic blood pressure114 mm[Hg]8480-6S
1996-05-27Diastolic blood pressure72 mm[Hg]8462-4S
1996-05-27Heart rate60 /min8867-4S
1996-05-27Respiratory rate14 /min9279-1S
1996-05-27Body temperature36.7 Cel8310-5S
1996-05-27Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1996-07-21Body height170 cm8302-2S
1996-07-21Body weight60.1 kg29463-7S
1996-07-21Body mass index (BMI) [Ratio]20.8 kg/m239156-5S
1996-07-21Systolic blood pressure108 mm[Hg]8480-6S
1996-07-21Diastolic blood pressure68 mm[Hg]8462-4S
1996-07-21Heart rate62 /min8867-4S
1996-07-21Respiratory rate14 /min9279-1S
1996-07-21Body temperature36.6 Cel8310-5S
1996-07-21Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1996-10-20Body height170 cm8302-2S
1996-10-20Body weight60.9 kg29463-7S
1996-10-20Body mass index (BMI) [Ratio]21.1 kg/m239156-5S
1996-10-20Systolic blood pressure110 mm[Hg]8480-6S
1996-10-20Diastolic blood pressure70 mm[Hg]8462-4S
1996-10-20Heart rate54 /min8867-4S
1996-10-20Respiratory rate14 /min9279-1S
1996-10-20Body temperature36.6 Cel8310-5S
1996-10-20Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1996-08-25Body height170 cm8302-2S
1996-08-25Body weight60.6 kg29463-7S
1996-08-25Body mass index (BMI) [Ratio]21 kg/m239156-5S
1996-08-25Systolic blood pressure110 mm[Hg]8480-6S
1996-08-25Diastolic blood pressure70 mm[Hg]8462-4S
1996-08-25Heart rate56 /min8867-4S
1996-08-25Respiratory rate14 /min9279-1S
1996-08-25Body temperature36.6 Cel8310-5S
1996-08-25Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
EEG and MRI with susceptibility-weighted imaging within one week, and an epilepsy consultation within two weeks1996-05-05completedEEG in two days, MRI in six, consultation at two weeks
No further seizures on an antiseizure medication she tolerates1996-10-20completedNo seizure in six months; levetiracetam tolerated after early irritability settled
Neurosurgical evaluation of the cavernous malformation and a shared decision about lesionectomy within two months1996-07-21completedSeen by neurosurgery at three weeks; complete lesionectomy at eight weeks
Safety plan in place: no driving until cleared, water and height safety, SUDEP discussion, and a nocturnal seizure detection plan1996-05-27completedDriving stopped and reported as California requires; SUDEP discussed (one visit late, recorded as a deviation); detection watch in use
Graded return to full sprint training within four months of surgery1996-10-20completedFull training at four months after surgery

Interventions

InterventionStatusGuideline
Neurology (epilepsy) consultation within two weeks to interpret the EEG and MRI, decide whether this is epilepsy, and advise on antiseizure medication, surgery and safetycompletedGL-AAN-FIRSTSZ-2015, GL-ILAE-DEF-2014
Evaluation of a seizure in an adult: history from her and witnesses' accounts, examination, blood count, electrolytes, glucose, calcium, magnesium, kidney and liver tests and creatine kinase, a pregnancy test, a sleep-deprived EEG, and MRI of the brain with an epilepsy protocol including susceptibility-weighted imaging; records of her earlier seizure care requestedcompletedGL-AAN-FIRSTSZ-2015
Safety from today: no driving, and the report of a disorder characterized by lapses of consciousness that California requires of physicians, explained to her before it is sent; no swimming alone or bathing in a tub, showers instead; no heights or working alone near water; seizure first aid and a written seizure action plan, calling emergency services for a seizure lasting five minutes or morecompletedGL-CA-DMV-2024, GL-AAN-FIRSTSZ-2015
Levetiracetam 500 mg twice daily, chosen for a woman who could become pregnant (low risk of birth defects, no interaction with hormonal contraception), with folic acid 0.4 mg daily; valproate avoided because of its risk of major malformations and lower intelligence in children exposed in pregnancy; contraception and pregnancy planning discussed; mood and irritability checked with the PHQ-9 at each visitcompletedGL-AAN-TERATO-2024, GL-AAN-FIRSTSZ-2015, GL-ILAE-DEF-2014
Neurosurgical evaluation of the epileptogenic cavernous malformation, with lesionectomy including the hemosiderin rim if she chooses itcompletedGL-CCM-2017
SUDEP counseling as the AAN/AES guideline requires: what it is, that tonic-clonic seizures are the main risk, and how to lower it (take every dose, keep regular sleep, avoid alcohol excess, aim for no tonic-clonic seizures); nocturnal supervision or a seizure detection watchcompletedGL-AAN-SUDEP-2017, GL-ILAE-DETECT-2021
Graded return to training after surgery: walking and stationary cycling from two weeks, running from four to six weeks, sprint sessions from six to eight weeks, full training by three to four months, with no heavy lifting until the craniotomy has healed; swimming only with a companion who knows seizure first aidcompletedGL-CCM-2017, GL-AAN-FIRSTSZ-2015
Long term: levetiracetam for at least two years after surgery, then a shared decision about tapering with an EEG; driving when the California DMV clears her after a seizure-free period; MRI only for new symptoms after a complete resectioncompletedGL-CCM-2017, GL-CA-DMV-2024, GL-AAN-FIRSTSZ-2015

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Florence Griffith Joyner (athlete profile) Olympedia biography
SRC-0002 Griffith Joyner, Florence (biographical entries) Encyclopedia.com biography
SRC-0003 Flo Jo reportedly doing fine after having seizure on plane (The Associated Press) The Spokesman-Review other
SRC-0004 Rebelo Anderson K. The uneasy death of Florence Griffith Joyner Salon other
SRC-0005 No direct drug link to FloJo death The Irish Times other
SRC-0006 Joyner autopsy reveals seizure (The Associated Press) CBS News other
SRC-0007 Autopsy proves Flo-Jo suffered an epileptic seizure World Athletics (IAAF) other
SRC-0008 Seizure, suffocation caused Flojo's death Deseret News other
SRC-0009 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the ILAE 2014 diagnosis after one seizure with a cavernous malformation (and earlier seizures by history), levetiracetam rather than lamotrigine, early lesionectomy after one evaluated seizure, the California reporting duty, the SUDEP counseling and its one-visit delay, and the return-to-training schedule.
provenance reviewnot_startedRecent-death rule: only what was reported during her life (the Associated Press report of the 1996 seizure) and the coroner's findings as reported by news organizations and World Athletics, plus Olympedia and Encyclopedia.com for her life and career. The earlier treated seizures come from coroner's records reported by Salon and are graded probable.
safe messaging reviewnot_startedNo mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Her death is recorded once, without detail. No relative is named or given a role in the modern episode, and no statement, decision or health fact is attributed to any relative. Rumors about performance-enhancing drugs are not part of the clinical record.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.